U.S. will not participate in COVAX project to develop coronavirus vaccine

By | September 1, 2020
U.S. will not participate in COVAX project to develop coronavirus vaccine

The United States does not want to be constrained by international organizations under the influence of the “corrupt World Health Organization,” said White House press secretary Judd Deere
The United States will not participate in COVAX’s international initiative to develop, manufacture, and distribute a new type of coronavirus vaccine. As The Washington Post reported on Tuesday, White House Deputy Press Secretary Judd Deere said. “The United States will continue to work with our international partners to ensure victory over the coronavirus, but we will not be constrained by international organizations under the influence of the corrupt World Health Organization (WHO),” he said.

The COVAX project is run by the Global Alliance for Vaccines and Immunization (GAVI), the Coalition for Epidemic Preparedness Innovation (CEPI), WHO, and multinational vaccine-producing corporations that see the tool as an additional source of government funding.

The aim of the mechanism is to invest in some 12 different vaccines and to ensure that they are accessed fairly early when they are marketed. About 2 billion doses of the vaccine are expected to be distributed with the assistance of COVAX by the end of 2021.

Last week, the WHO Director-General announced that 172 countries had joined the mechanism.